AMGN (STOCKS)
Amgen Inc
$366.750000
+2.100000 (+0.58%)
Prev close: $364.650000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Robert A. Bradway
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $197,331.75M
- Employees
- 28,000
- P/E (TTM)
- 25.63
- P/B (TTM)
- 22.70
- Dividend Yield
- 261.07%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
16
Buy
16
Hold
2
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$5.29 | $4.83 | +0.4617 | +9.56% |
|
Sep 2025 (Q3)
|
$5.64 | $5.11 | +0.5256 | +10.28% |
|
Jun 2025 (Q2)
|
$6.02 | $5.39 | +0.6276 | +11.64% |
|
Mar 2025 (Q1)
|
$4.90 | $4.39 | +0.5145 | +11.73% |
Financial Statements
| Assets | $90.14B |
| Current Assets | $27.89B |
| Inventory | $6.35B |
| Other Current Assets | $21.54B |
| Noncurrent Assets | $62.26B |
| Fixed Assets | $7.22B |
| Intangible Assets | $23.14B |
| Other Non-current Assets | $31.90B |
| Liabilities | $80.52B |
| Current Liabilities | $21.79B |
| Accounts Payable | $2.84B |
| Other Current Liabilities | $18.95B |
| Noncurrent Liabilities | $58.73B |
| Long-term Debt | $54.59B |
| Other Non-current Liabilities | $4.14B |
| Equity | $9.62B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $9.62B |
| Liabilities And Equity | $90.14B |